Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,11 USD | -3,21% |
|
-1,86% | -7,86% |
Attività
Numero di dipendenti: 23
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Treatments for Solid Tumor Cancers
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -46,35% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -46,35% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
James Oliviero
CEO | Chief Executive Officer | 48 | 13/10/15 |
William Gray
DFI | Director of Finance/CFO | 36 | 01/02/16 |
Michael Weiss
CHM | Chairman | 58 | 01/03/15 |
Director/Board Member | 68 | 10/11/14 | |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 68 | 10/11/14 | |
Michael Weiss
CHM | Chairman | 58 | 01/03/15 |
Christian Béchon
BRD | Director/Board Member | 63 | 16/10/18 |
Barry Salzman
BRD | Director/Board Member | 62 | 01/01/16 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 01/08/15 |
James Oliviero
CEO | Chief Executive Officer | 48 | 13/10/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 700 000 | 0 | 0 | 79,87 % |
Azione B | 1 | 36 216 279 | 29 485 050 ( 81,41 %) | 0 |
Coordinate società
Checkpoint Therapeutics, Inc.
95 Sawyer Road Suite 110
02453, Waltham
+781 652 4500
http://www.checkpointtx.com![Indirizzo Checkpoint Therapeutics, Inc.(CKPT)](https://cdn.zonebourse.com/static/address/35939980.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-7,86% | 80,35 Mln | |
+18,97% | 45,34 Mrd | |
+42,78% | 40,42 Mrd | |
-10,06% | 37,92 Mrd | |
+31,15% | 31,75 Mrd | |
-7,79% | 27,71 Mrd | |
+13,32% | 26,52 Mrd | |
+43,05% | 13,96 Mrd | |
+31,28% | 12,44 Mrd | |
-7,41% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione CKPT
- Società Checkpoint Therapeutics, Inc.